NEW YORK (GenomeWeb) – Proteomics firm Caprion Biosciences said today that it has been acquired by London-based healthcare investment firm GHO Capital.

GHO purchased the company for an undisclosed amount from Chicago Growth Partners, Caprion's majority shareholder since 2012. Caprion said that it will continue to operate out of its current Montreal headquarters under the leadership of its existing management team.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.